Submission Details
| 510(k) Number | K143615 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | December 19, 2014 |
| Decision Date | January 26, 2016 |
| Days to Decision | 403 days |
| Submission Type | Traditional |
| Review Panel | Anesthesiology (AN) |
| Summary | Statement |
K143615 is an FDA 510(k) clearance for the Antistatic Compact Space Chamber, a Holding Chambers, Direct Patient Interface (Class II — Special Controls, product code NVP), submitted by Medical Developments International Limited (Springvale, AU). The FDA issued a Cleared decision on January 26, 2016, 403 days after receiving the submission on December 19, 2014. This device falls under the Anesthesiology review panel. Regulated under 21 CFR 868.5630.
| 510(k) Number | K143615 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | December 19, 2014 |
| Decision Date | January 26, 2016 |
| Days to Decision | 403 days |
| Submission Type | Traditional |
| Review Panel | Anesthesiology (AN) |
| Summary | Statement |
| Product Code | NVP — Holding Chambers, Direct Patient Interface |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 868.5630 |
| Definition | Holding Chambers Are Devices That Are Used With Nebulizers And Metered Dose Inhalers And Are Comprised Of A Reservoir Into Which An Aerosol Medication Is Dispensed. A Holding Chamber Uses A Valved Mouthpiece Through Which The Patient Inhales The Dispensed Medication. Holding Chambers Are Intended To Minimize Delivery Of Large Aerosolized Particles |